Beacon is for Biotech Companies

Connect scientific, clinical and commercial intelligence within one platform, to prove differentiation, prioritise resources and advance your most promising programmes with confidence.

Trusted by 24/25 top Pharma companies

The Challenges Facing Biotech Companies

Proving Differentiation:

Biotechs must demonstrate why their science, platform or lead asset stands apart in increasingly crowded target and modality landscapes.

Limited Time and Resources:

Lean teams must make high-impact research, clinical and commercial decisions without the scale or specialist resources of larger organisations.

Translational and Development Risk:

Early scientific promise must translate into credible development plans, differentiated trials and compelling evidence for future milestones.

Pressure to Secure Funding and Partners:

Company momentum can depend on building a defensible narrative that withstands scrutiny from investors, partners and potential acquirers.

One Platform. Multiple Teams. Smarter Decisions.

Beacon gives lean, cross-functional biotech teams one connected source of intelligence to strengthen science, development strategy, partnering and fundraising.

Research & Translational

How Beacon Helps Research & Translational Teams

Benchmark targets, modalities, models and preclinical evidence against the full landscape
Connect design choices and experimental approaches with downstream clinical outcomes
Identify scientific white space and opportunities for meaningful differentiation
Strengthen translational hypotheses with traceable competitor evidence

Clinical Development

How Beacon helps Clinical Development Teams

Benchmark trial designs, endpoints, comparators and patient selection strategies
Track competing trials, protocol changes, milestones and emerging readouts
Use relevant precedents to refine development plans and reduce avoidable risk
Support faster go/no-go decisions with connected preclinical and clinical intelligence

 

Business Development & Partnering

How Beacon Helps Business Development & Partnering Teams

Identify best-fit partners, licensees and potential acquirers based on strategic alignment
Benchmark comparable assets, companies, deals and development progress
Build data-backed partnering materials that clearly demonstrate differentiation
Strengthen valuation and negotiation with scientific, clinical and commercial context

Competitive & Scientific Strategy

How Beacon Helps Competitive & Scientific Strategy Teams

Monitor competitors, new entrants, technology shifts and key development milestones
Prioritise programmes and resources using a complete view of the landscape
Identify threats, whitespace and evidence gaps before they affect strategy
Translate fragmented activity into decision-ready updates for internal teams

Senior Leadership

How Beacon Helps Senior Leadership Teams

Maintain an up-to-date view of company positioning and the external landscape
Align scientific, clinical, partnering and funding priorities
Prepare confidently for investor, board and strategic partner discussions
Make defensible resource allocation decisions while protecting runway

See Beacon in Action

Why Leading Biotech Teams Choose Beacon

Beacon captures the depth, context and scientific intelligence that generic databases and AI engines often miss, helping biotech teams prove differentiation, reduce blind spots and support every decision to move the company forward.

Modality & Disease-Specific Datasets

Analyze the full competitive landscape. Includes the 20-30% of data AI engines miss.

Subject Matter Expert-Led Curation

Curated by scientists, trusted by strategists to deliver decision-grade intelligence

Holistic Preclinical & Clinical Data

From discovery to clinic, depth and context no generic platform can match.

Granular Ontologies & Modality-Specific Data

From “who is active” to “what wins” benchmark what drives differentiation.

Structured, AI-ready Data

Power your analytics and automation workflows. Gold-standard data in, gold-standard decisions out.

Why Generic Databases and AI Engines Fall Short

The difference is clear. Beacon delivers decision-grade intelligence designed specifically for drug development.

What Matters Generic Databases AI Engines Beacon
Landscape Completeness Broad, but shallow Highly variable; significant omissions Access the full landscape, including the 20-30% others miss
Preclinical depth Limited or absent Largely missing from model outputs Core strength, curated from grey literature upwards
Scientific granularity Company, indication, phase of development Unstructured narrative text 90+ modality-specific filters and ontologies
Curation Largely automated aggregation None, model inference only Curated by sector scientists, zero tolerance for errors
Consistency Varies with refresh cycles and versioning Answers vary between identical queries Deterministic, the same query returns the same result
Defensibility Partial sourcing; re-validation needed Sources often missing, paraphrased or fabricated 100% traceable, board and portfolio ready

Supporting Better Decisions at Every Stage of the Biotech Journey

From validating the science to securing investment, advancing clinical programmes and building partnerships, Beacon provides the connected intelligence biotech companies need at every stage.

Discovery

Validate targets, modalities and scientific whitespace

Preclinical

Benchmark models, efficacy, safety and translation

Clinical

Refine trial strategy and track competing evidence

Partnering

Identify counterparties and prove asset differentiation

Growth

Support funding, portfolio and strategic decisions

Are you ready to see the full landscape?

Connect the evidence behind your science, strengthen your development narrative and make every strategic decision with greater confidence.

Request a Demo

Menu
Search Icon
Close Icon
Search